by Eric Christianson | May 12, 2024 | Clinical Pharmacy News and New Drug Updates, Gastrointestinal Medication and Disease State Clinical Pearls
On November 1, 2023, the U.S. Food and Drug Administration (FDA) approved VOQUEZNA® (vonoprazan) as a new treatment for the healing and maintenance of erosive esophagitis and the relief of heartburn associated with erosive esophagitis in adults. This FDA approval...
